All the pharmacists reported good relationships with their service users. All service users described satisfactory relationships with their current

community pharmacist but some reported problems with previous community pharmacists. In general, service users whose pharmacists had expressed a positive view regarding the value of substitution therapy reported a stronger motivation to remain in treatment. All service users remained in treatment for the limited duration of the study. The similarity of common themes indicates a good mutual understanding by both parties of each other’s priorities. However, unsurprisingly, each group of interviewees had different concerns in relation to each of these themes; e.g. pharmacists were concerned about safety and security in the pharmacy, whereas service users’ main concerns Selleck Everolimus were respect and privacy. Even those pharmacists who were least sceptical about the value of treatment, and who appeared to have the best rapport with their service users, expressed doubts about long term outcomes for service users. This research question would merit further exploration in a larger, longer term study to determine how pharmacists’ views affect treatment completion rates. 1. Matheson, C., Bond, C.M. & Mollison, J. Attitudinal factors associated with community pharmacists’ involvement in services for drug misusers. Addiction find more 1999; 94: 1349–1359. 2. Simpson, D. D., Joe, G. W., Rowan-Szal, G. A., & Greener,

J. M. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 1997; 14: 565–572. Christine Bond1, Emma Scobie Scott1, Peter Helms1, David Shaw2, John Haughney1 1University of Aberdeen, Aberdeen, UK, 2Institute Tolmetin for Biomedical Ethics, Basel, Switzerland This study explored the acceptability, to parents and young people, of linking routinely acquired NHS data for paediatric pharmaco-vigilance? Themes identified were safety, privacy/confidentiality, data

linkage, trust, and public engagement. A paediatric pharma-covigilance database derived from linkage of routinely collected health-care data was understood and acceptable Off-label prescribing is common in children (1) and a recognised risk factor for adverse drug reactions (ADRs) (2). Under reporting of ADRs using the UK Yellow Card Scheme may delay identification of ADRs and impact on the quality of prescribing. In Scotland the Community Health Index (CHI) number (a unique personal identifier) is included in the majority of records of all NHS contacts. These include primary care, secondary care and dispensing information. Recent advances in archiving have facilitated deterministic linkage of data, from different datasets, at individual patient level. The aim of this study was to assess the acceptability of this linkage, to young people and concerned adults, for the purpose of paediatric pharmaco-vigilance. This study is part of the CHIMES programme of work (Child Medical Records for Safer Medicines).